203,834 Shares in The Cooper Companies, Inc. $COO Bought by Heartland Advisors Inc.

Heartland Advisors Inc. acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, Holdings Channel.com reports. The firm acquired 203,834 shares of the medical device company’s stock, valued at approximately $14,617,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after purchasing an additional 7,363 shares during the last quarter. First Trust Advisors LP boosted its holdings in Cooper Companies by 115.8% in the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after buying an additional 73,165 shares during the last quarter. Cresset Asset Management LLC acquired a new stake in Cooper Companies in the 2nd quarter worth about $291,000. Cerity Partners LLC increased its stake in Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after buying an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. increased its stake in Cooper Companies by 2.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after buying an additional 973 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

COO has been the subject of a number of research analyst reports. Needham & Company LLC reduced their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. BNP Paribas Exane lowered their price target on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research note on Monday, June 8th. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Robert W. Baird reduced their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, June 5th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $81.64.

Cooper Companies Trading Up 0.1%

Shares of COO opened at $76.22 on Friday. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The firm has a market capitalization of $14.87 billion, a P/E ratio of 64.59, a P/E/G ratio of 1.99 and a beta of 0.83. The firm has a 50-day moving average price of $71.93 and a 200 day moving average price of $71.16. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the previous year, the firm earned $0.96 earnings per share. Cooper Companies’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.